 CAMBRIDGE, Mass., Jan. 31, 2022 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ: SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today announced that two abstracts including an oral presentation on MPS-1 have been accepted for presentation at the upcoming 18th Annual WORLDSymposiumTM, being held February 7-11th in San Diego. 